Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity

Kathleen M. McAndrews(The University of Texas MD Anderson Cancer Center), Raghu Kalluri(The University of Texas MD Anderson Cancer Center)
JCI Insight
August 14, 2020
Cited by 143


Related Papers